Drugs / Ampicillin/sulbactam
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07107477 Comparator | May 2025 → Sep 2027 expected | preterm premature rupture of the membranes | The Central and Eastern European Gynecologic Oncology Group | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ampicillin/sulbactam | “Ampicillin/sulbactam 3g IV every 6 hours + Gentamicin 5 mg/kg IV” NCT07107477 ↗ |
| Route | Intravenous | “Ampicillin/sulbactam 3g IV every 6 hours” NCT07107477 ↗ |